A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki

Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki Herantis Pharma Plc Company release 6…

Read More

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema Herantis Pharma Plc Company release…

Read More

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 30 May 2018 at 9:30 am Herantis Pharma Oyj - Managers'…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.